Nanoparticle Drug Delivery Systems for α-Mangostin
Nasrul Wathoni,1 Agus Rusdin,1,2 Keiichi Motoyama,3 I Made Joni,4 Ronny Lesmana,5 Muchtaridi Muchtaridi6 1Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang 45363, Indonesia; 2Department of Pharmacy, Faculty of Sports and Health, Univers...
Guardado en:
Autores principales: | Wathoni N, Rusdin A, Motoyama K, Joni IM, Lesmana R, Muchtaridi M |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5f10ec62dd944778a7d5584103c3cc13 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Local Delivery and Glioblastoma: Why Not Combining Sustained Release and Targeting?
por: Claire Gazaille, et al.
Publicado: (2021) -
Targeted Delivery of Therapeutic Gas by Microbubbles
por: Lingling Xu, MM, Yihan Chen, MM, Qiaofeng Jin, PhD, Li Zhang, MD, Wenpei Fu, BS, Shan Lin, MM, Ling Lin, BS, Rui Wang, BS, Dandan Chen, MM, Zhengyang Han, MM, Mingxing Xie, MD, Yali Yang, MD
Publicado: (2021) -
Mangosteen xanthone γ-mangostin exerts lowering blood glucose effect with potentiating insulin sensitivity through the mediation of AMPK/PPARγ
por: Sih-Pei Chen, et al.
Publicado: (2021) -
Inhalation drug delivery devices: technology update
por: Ibrahim M, et al.
Publicado: (2015) -
Evaluation of the angled Episcissors-60® episiotomy scissors in spontaneous vaginal deliveries
por: Patel RP, et al.
Publicado: (2014)